Omar Kreidieh

Omar Kreidieh

Auto-generated profile, based on publicly available information

Omar Kreidieh

Cardiology Department, Heart and Vascular Institute, Tulane University School of Medicine (Y.L., C.L., G.B., C.M., Y.C., H.Y., M.B., Y.J., A.H., C.Z., A.P., O.K., H.F., N.M.).

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
AAAla Assaf
Ala Assaf
MMMario Mekhael
Mario Mekhael
CNCharbel Noujaim
Charbel Noujaim
NCNour Chouman
Nour Chouman
HYHadi Younes
Hadi Younes
EDEoin Donnellan
Eoin Donnellan
The amount of fibrosis in the left atrium (LA) predicts atrial fibrillation (AF) recurrence after catheter ablation (CA). We aim to identify whether regional variations in LA fibrosis affect AF recurrence. This post hoc analysis of the DECAAF II trial includes 734 patients with persistent AF undergoing first-time CA who underwent late gadolinium enhancement magnetic resonance imaging (LGE-MRI) within 1 month prior to ablation and were randomized to MRI-guided fibrosis ablation in addition to standard pulmonary vein isolation (PVI) or standard PVI only. The LA wall was divided into seven regions: anterior, posterior, septal, lateral, right pulmonary vein (PV) antrum, left PV antrum, and left atrial appendage (LAA) ostium. Regional fibrosis percentage was defined as a region’s fibrosis prior to ablation divided by total LA fibrosis. Regional surface area percentage was defined as an area’s surface area divided by the total LA wall surface area before ablation. Patients were followed up for a year with single-lead electrocardiogram (ECG) devices. The left PV had the highest regional fibrosis percentage (29.30 ± 14.04%), followed by the lateral wall (23.23 ± 13.56%), and the posterior wall (19.80 ± 10.85%). The regional fibrosis percentage of the LAA was a significant predictor of AF recurrence post-ablation (odds ratio = 1.017, P = 0.021), and this finding was only preserved in patients receiving MRI-guided fibrosis ablation. Regional surface area percentages did not significantly affect the primary outcome. We have confirmed that atrial cardiomyopathy and remodelling are not a homogenous process, with variations in different regions of the LA. Atrial fibrosis does not uniformly affect the LA, and the left PV antral region has more fibrosis than the rest of the wall. Furthermore, we identified regional fibrosis of the LAA as a significant predictor of AF recurrence post-ablation in patients receiving MRI-guided fibrosis ablation in addition to standard PVI.

20 September 2023 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
AAAla Y. Assaf
Ala Y. Assaf
CNCharbel Noujaim
Charbel Noujaim
MMMario Mekhael
Mario Mekhael
HYHadi Younes
Hadi Younes
NCNour Chouman
Nour Chouman
OKOmar Kreidieh
Omar Kreidieh

5 April 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MMMario Mekhael
Mario Mekhael
CHChan Ho
Chan Ho
CNCharbel Noujaim
Charbel Noujaim
AAAla Assaf
Ala Assaf
HYHadi Younes
Hadi Younes
EDEoin Donnellan
Eoin Donnellan
Background: The WEAICOR (Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19) study was a prospective observational study that used continuous monitoring to detect and analyze biometrics. Compliance to wearables was a major challenge when conducting the study and was crucial for the results. Objective: The aim of this study was to evaluate patients’ compliance to wearable wristbands and determinants of compliance in a prospective COVID-19 cohort. Methods: The Biostrap (Biostrap USA LLC) wearable device was used to monitor participants’ biometric data. Compliance was calculated by dividing the total number of days in which transmissions were sent by the total number of days spent in the WEAICOR study. Univariate correlation analyses were performed, with compliance and days spent in the study as dependent variables and age, BMI, sex, symptom severity, and the number of complications or comorbidities as independent variables. Multivariate linear regression was then performed, with days spent in the study as a dependent variable, to assess the power of different parameters in determining the number of days patients spent in the study. Results: A total of 122 patients were included in this study. Patients were on average aged 41.32 years, and 46 (38%) were female. Age was found to correlate with compliance (r=0.23; P=.01). In addition, age (r=0.30; P=.001), BMI (r=0.19; P=.03), and the severity of symptoms (r=0.19; P=.03) were found to correlate with days spent in the WEAICOR study. Per our multivariate analysis, in which days spent in the study was a dependent variable, only increased age was a significant determinant of compliance with wearables (adjusted R2=0.1; β=1.6; P=.01). Conclusions: Compliance is a major obstacle in remote monitoring studies, and the reasons for a lack of compliance are multifactorial. Patient factors such as age, in addition to environmental factors, can affect compliance to wearables.

4 February 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
MMMario Mekhael
Mario Mekhael
BSBotao Shan
Botao Shan
CNCharbel Noujaim
Charbel Noujaim
NCNour Chouman
Nour Chouman
AAAlaa Assaf
Alaa Assaf
EDEoin Donnellan
Eoin Donnellan
The aim of our study was to assess differences in post-ablation atrial fibrillation (AF) recurrence and burden and to quantify the change in LVEF across different congestive heart failure (CHF) subcategories of the DECAAF-II population. Differences in the primary outcome of AF recurrence between CHF and non-CHF groups was calculated. The same analysis was performed for the three subgroups of CHF and the non-CHF group. Differences in AF burden after the 3-month blanking period between CHF and non-CHF groups was calculated. Improvement in LVEF was calculated and compared across the three CHF groups. Improvement was also calculated across different fibrosis stages. There was no significant differences in AF recurrence and AF burden after catheter ablation between CHF and non-CHF patients and between different CHF subcategories. Patients with heart failure with reduced ejection fraction (HFrEF) experienced the greatest improvement in EF following catheter ablation (CA, 16.66% ± 11.98, P < 0.001) compared to heart failure with moderately reduced LVEF, and heart failure with preserved EF (10.74% ± 8.34 and 2.00 ± 8.34 respectively, P-value < 0.001). Moreover, improvement in LVEF was independent of the four stages of atrial fibrosis (7.71 vs. 9.53 vs. 5.72 vs. 15.88, from Stage I to Stage IV respectively, P = 0.115). Atrial fibrillation burden and recurrence after CA is similar between non-CHF and CHF patients, independent of the type of CHF. Of all CHF groups, those with HFrEF had the largest improvement in LVEF after CA. Moreover, the improvement in ventricular function seems to be independent of atrial fibrosis in patients with persistent AF.

19 April 2022 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
OKOmar Kreidieh
Omar Kreidieh
AVAllyson L. Varley
Allyson L. Varley
JRJorge Romero
Jorge Romero
DSDavid Singh
David Singh
JSJosh Silverstein
Josh Silverstein
JOJose Osorio
Jose Osorio

28 January 2024 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
OKOmar Kreidieh
Omar Kreidieh
THTina D. Hunter
Tina D. Hunter
SGSandeep Goyal
Sandeep Goyal
AVAllyson L. Varley
Allyson L. Varley
CTChristopher Thorne
Christopher Thorne
IRInvestigators of the REAL AF registry
Investigators of the REAL AF registry